Literature DB >> 29737184

Obstructive sleep apnoea is more prevalent in men with schizophrenia compared to general population controls: results of a matched cohort study.

Hannah Myles1, Andrew Vincent2, Nicholas Myles3, Robert Adams4, Madhu Chandratilleke5, Dennis Liu6, Jeremy Mercer5, Andrew Vakulin7, Gary Wittert8, Cherrie Galletly9.   

Abstract

OBJECTIVES: : Obstructive sleep apnoea (OSA) may be more common in people with schizophrenia compared to the general population, but the relative prevalence is unknown. Here, we determine the relative prevalence of severe OSA in a cohort of men with schizophrenia compared to representative general population controls, and investigate the contribution of age and body mass index (BMI) to differences in prevalence.
METHODS: : Rates of severe OSA (apnoea-hypopnoea index > 30) were compared between male patients with schizophrenia and controls from a representative general population study of OSA.
RESULTS: : The prevalence of severe OSA was 25% in the schizophrenia group and 12.3% in the general population group. In subgroups matched by age, the relative risk of severe OSA was 2.9 ( p = 0.05) in the schizophrenia subjects, but when adjusted for age and BMI, the relative risk dropped to 1.7 and became non-significant ( p = 0.17).
CONCLUSIONS: : OSA is prevalent in men with schizophrenia. Obesity may be an important contributing factor to the increased rate of OSA.

Entities:  

Keywords:  BMI; apnoea–hypopnoea index; obesity; obstructive sleep apnoea; psychosis; schizophrenia

Mesh:

Year:  2018        PMID: 29737184     DOI: 10.1177/1039856218772241

Source DB:  PubMed          Journal:  Australas Psychiatry        ISSN: 1039-8562            Impact factor:   1.369


  1 in total

1.  Cognition in schizophrenia improves with treatment of severe obstructive sleep apnoea: A pilot study.

Authors:  Hannah Myles; Nicholas Myles; Ching Li Chai Coetzer; Robert Adams; Madhu Chandratilleke; Dennis Liu; Jeremy Mercer; Andrew Vakulin; Andrew Vincent; Gary Wittert; Cherrie Galletly
Journal:  Schizophr Res Cogn       Date:  2018-11-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.